<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Behav Addict</journal-id>
<journal-id journal-id-type="iso-abbrev">J Behav Addict</journal-id>
<journal-id journal-id-type="pmc">jba</journal-id>
<journal-id journal-id-type="publisher-id">JBA</journal-id>
<journal-title-group>
<journal-title>Journal of Behavioral Addictions</journal-title>
</journal-title-group>
<issn pub-type="ppub">2062-5871</issn>
<issn pub-type="epub">2063-5303</issn>
<publisher>
<publisher-name>Akadémiai Kiadó</publisher-name>
<publisher-loc>Budapest</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31446765</article-id>
<article-id pub-id-type="pmc">7044627</article-id>
<article-id pub-id-type="doi">10.1556/2006.8.2019.40</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Full-Length Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of GDNF and CNTNAP2 gene variants with gambling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Das</surname>
<given-names>Arundhuti</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pagliaroli</surname>
<given-names>Luca</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vereczkei</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kotyuk</surname>
<given-names>Eszter</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Langstieh</surname>
<given-names>Banrida</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demetrovics</surname>
<given-names>Zsolt</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barta</surname>
<given-names>Csaba</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="COR1">*</xref>
</contrib>
<aff id="A1"><label>1</label>Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, <institution>Semmelweis University</institution>, Budapest, <country>Hungary</country></aff>
<aff id="A2"><label>2</label>Department of Anthropology, <institution>Utkal University</institution>, Bhubaneswar, <country>India</country></aff>
<aff id="A3"><label>3</label>Indian Council of Medical Research, <institution>Regional Medical Research Center</institution>, Bhubaneswar, <country>India</country></aff>
<aff id="A4"><label>4</label>MTA-ELTE Lendület Adaptation Research Group, Institute of Psychology, <institution>ELTE Eötvös Loránd University</institution>, Budapest, <country>Hungary</country></aff>
<aff id="A5"><label>5</label>Department of Anthropology, <institution>North Eastern Hill University</institution>, Shillong, <country>India</country></aff>
</contrib-group>
<author-notes>
<corresp id="COR1"><label>*</label>Corresponding author: Csaba Barta, MD, PhD; Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, 37-47 Tuzolto Street, Budapest, 1094, PO Box 260, Hungary; Phone: +36 1 459 1500 ext. 60137; Fax: +36 1 266 7480; E-mail: <email>barta.csaba@med.semmelweis-univ.hu</email></corresp>
</author-notes>
<pub-date date-type="pub" publication-format="electronic">
<day>26</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date date-type="pub" publication-format="print">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>8</volume>
<issue>3</issue>
<fpage>471</fpage>
<lpage>478</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Author(s)</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Akadémiai Kiadó, Budapest</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated. (SID_1)</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="jba-08-03-40.pdf"></self-uri>
<abstract>
<sec sec-type="background and aims">
<title>Background and aims</title>
<p>Some form of gambling can be observed in nearly every society, as the gratification felt upon winning in uncertain conditions is universal. A culturally distinct form of gambling, associated with a traditional sporting event of archery known as “<italic>teer</italic>,” is innate to the province of Meghalaya, India. The objective of this study was to find genetic variants underlying this unique form of behavioral addiction. To better understand game-based gambling, we studied genetic variants related to dopaminergic pathways and other genes previously linked to various psychological disorders.</p>
</sec>
<sec sec-type="methods">
<title>Methods</title>
<p>This study was carried out on a sample of 196 Indo-Aryan adults from Shillong, Meghalaya. Genotyping of glial cell line-derived neurotrophic factor (GDNF) polymorphisms was carried out using real-time PCR. We further investigated 32 single nucleotide polymorphisms located in the 3′ UTR of additional genes of interest using an OpenArray<sup>®</sup> real-time PCR platform.</p>
</sec>
<sec sec-type="results">
<title>Results</title>
<p>Case–control analysis revealed a significant association between GDNF variant rs2973033 (<italic>p</italic> = .00864, χ<sup>2</sup> = 13.132, <italic>df</italic> = 2) and contactin-associated protein-like 2 (CNTNAP2) variant rs2530311 (<italic>p</italic> = .0448, χ<sup>2</sup> = 13.132, <italic>df</italic> = 2) with gambling.</p>
</sec>
<sec sec-type="discussion and conclusions">
<title>Discussion and conclusions</title>
<p>Association of the GDNF gene with gambling could be attributed to its involvement in the development and survival of dopaminergic neurons. Our result is in good agreement with previous data indicating the role of GDNF in certain substance addictions. Several rare variants in the CNTNAP2 gene were also implicated in alcohol addiction in a previous study. This pilot study provides further support for the role of GDNF and CNTNAP2 in addiction behaviors.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="key-words">
<kwd>addiction</kwd>
<kwd>gambling</kwd>
<kwd>genetic</kwd>
<kwd>GDNF</kwd>
<kwd>CNTNAP2</kwd>
</kwd-group>
<funding-group>
<funding-statement><italic>Funding sources:</italic> AD was supported by Hungarian Scholarship Board Indian-Hungarian collaboration Scheme B Postgraduate program, 2014-2015: “Study on the genetic variants in gambling.” LP was financed by FP7-People-2012-ITN, project: TS-Eurotrain, grant number 316978. CB was supported by funding from the Merit-prize fellowship of Semmelweis University, the Bolyai János research fellowship of the Hungarian Academy of Sciences BO/00987/16/5; the ÚNKP-18-4 of the new National Excellence Program of the Ministry of Human Capacities; and the Baron Munchausen Program of the Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University. The study was also supported by the Hungarian National Research, Development and Innovation Office (grant numbers: K111938 and KKP126835). The study was completed with the support of the Hungarian Ministry of Human Capacities (ELTE Institutional Excellence Program, 783-3/2018/FEKUTSRAT).</funding-statement>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="4"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="54"></ref-count>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Substance-related and addictive disorders are conditions characterized using different classes of drugs that produce reward when used in excess, as defined by the fifth edition of <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (DSM-5; <xref ref-type="bibr" rid="B3">American Psychiatric Association, 2013</xref>). Game-based gambling is considered a prototypical example of behavioral (non-substance) addiction (<xref ref-type="bibr" rid="B38">Robbins &amp; Clark, 2015</xref>) in the DSM-5. It is known that about 70%–90% of people gamble at some time in their lives (<xref ref-type="bibr" rid="B41">Shaffer, Hall, &amp; Vander Bilt, 1999</xref>; <xref ref-type="bibr" rid="B50">Welte, Barnes, Tidwell, Hoffman, &amp; Wieczorek, 2015</xref>); however, only a small portion (1%–2%) will develop a gambling disorder (<xref ref-type="bibr" rid="B53">Xuan et al., 2017</xref>).</p>
<p>Gambling involves wagering money or other valuable objects on an event where the outcome is not certain. Thus, gambling implies the willingness to risk something valuable with the hope of a reward. Excessive gambling, however, can lead to negative consequences in subjective well-being by affecting several aspects of daily life, such as mental state, behavior, economy, and relationships. Symptoms are very similar to those observed in substance use dependence (<xref ref-type="bibr" rid="B19">Grant, Potenza, Weinstein, &amp; Gorelick, 2010</xref>).</p>
<p>This study was conducted on participants practicing a distinct form of gambling related to the game of archery. In the region of Meghalaya, India, archery (called “<italic>teer</italic>”) is a traditional game among the Khasi population. This sport has been legalized by the local government of Meghalaya and takes place twice a day in the capital city of Shillong. Within a designated arena, a group of professional archers aim and shoot hundreds of arrows at a target. Spectators bid on the last two digits (between 00 and 99) of the total number of arrows that will hit the target. Government-registered counters are spread across the city, and it is here that gamblers buy their tickets with the preferred two-digit number. Following the tournament, individuals who had bid the right guess may collect their prize money from the counters. Despite being a traditional Khasi sport, “<italic>teer</italic>” has gained so much popularity recently that other communities of Shillong also take part in this particular form of game-based gamble. Therefore, this pilot study was performed on a unique, culturally distinct phenotype, where even collection of the sample was a great challenge and as such it should be considered as an exploratory analysis.</p>
<p>Genetic studies of gambling behavior are sparse in literature (<xref ref-type="bibr" rid="B21">Gyollai et al., 2014</xref>). In this study conducted on the Indo-Aryan population from Shillong, we mainly focused on glial cell line-derived neurotrophic factor (GDNF), a gene involved in dopaminergic neuronal development, which has previously been found to be associated with methamphetamine (<xref ref-type="bibr" rid="B54">Yoshimura et al., 2011</xref>) and tobacco addiction (<xref ref-type="bibr" rid="B31">Kotyuk et al., 2016</xref>). In order to investigate the possible role of epigenetic regulation of gene expression in gambling, different single nucleotide polymorphisms (SNPs) located in 3′ untranslated regions (3′ UTRs) of additional candidate genes associated with gambling, such as catechol-O-methyltransferase (<xref ref-type="bibr" rid="B18">Grant, Potenza, Weinstein, &amp; Gorelick, 2015</xref>; <xref ref-type="bibr" rid="B20">Guillot, Fanning, Liang, &amp; Berman, 2015</xref>; <xref ref-type="bibr" rid="B48">Verdejo-Garcia et al., 2013</xref>), DRD2 (<xref ref-type="bibr" rid="B15">Fagundo et al., 2014</xref>; <xref ref-type="bibr" rid="B24">Hillemacher et al., 2016</xref>; <xref ref-type="bibr" rid="B28">Joutsa et al., 2014</xref>), GDNF (<xref ref-type="bibr" rid="B31">Kotyuk et al., 2016</xref>; <xref ref-type="bibr" rid="B40">Ron &amp; Janak, 2005</xref>), monoamine oxidase A (<xref ref-type="bibr" rid="B25">Ibanez et al., 2000</xref>), and solute carrier family 6 member 3 (<xref ref-type="bibr" rid="B15">Fagundo et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Kordi-Tamandani, Tajoddini, &amp; Salimi, 2015</xref>; <xref ref-type="bibr" rid="B46">Stolf et al., 2014</xref>). Some other genes earlier shown to be associated with either addiction, such as HTR2A (<xref ref-type="bibr" rid="B11">Cao et al., 2014</xref>; <xref ref-type="bibr" rid="B35">Perez-Rubio et al., 2017</xref>), CNR1 (<xref ref-type="bibr" rid="B13">Clarke et al., 2013</xref>; <xref ref-type="bibr" rid="B26">Icick et al., 2015</xref>), contactin-associated protein-like 2 (CNTNAP2; <xref ref-type="bibr" rid="B44">Song &amp; Zhang, 2014</xref>) and TNF (<xref ref-type="bibr" rid="B23">Heberlein et al., 2014</xref>), or with other psychiatric conditions, such as AADAC (<xref ref-type="bibr" rid="B8">Bertelsen et al., 2016</xref>), ACP1 (<xref ref-type="bibr" rid="B51">Willour et al., 2012</xref>), IL1RN (<xref ref-type="bibr" rid="B29">Kapelski et al., 2016</xref>), IMMP2L (<xref ref-type="bibr" rid="B36">Petek et al., 2001</xref>), LHX6 (<xref ref-type="bibr" rid="B33">Paschou et al., 2012</xref>), MEIS1 (<xref ref-type="bibr" rid="B22">Hammerschlag et al., 2017</xref>), MIR302A (<xref ref-type="bibr" rid="B9">Beveridge, Gardiner, Carroll, Tooney, &amp; Cairns, 2010</xref>), NTN4 (<xref ref-type="bibr" rid="B34">Paschou et al., 2014</xref>), and SLITRK1 (<xref ref-type="bibr" rid="B1">Abelson et al., 2005</xref>; <xref ref-type="bibr" rid="B45">Speed et al., 2008</xref>) were also included. It has been shown that microRNAs (miRNAs) regulate multiple signaling cascades implicated in several types of addictive disorders (<xref ref-type="bibr" rid="B5">Bali &amp; Kenny, 2013</xref>; <xref ref-type="bibr" rid="B42">Sim et al., 2017</xref>; <xref ref-type="bibr" rid="B43">Smith &amp; Kenny, 2017</xref>). Since the 3′ UTR of a gene serves for binding of various miRNAs, a polymorphism in these sequences might alter the binding affinity of regulatory miRNAs to their target messenger RNAs, therefore influencing the expression of the given gene.</p>
<p>We hypothesized that variants potentially affecting miRNA-directed regulation of gene expression may serve as risk factors for behavioral addictions, such as gambling.</p>
</sec>
<sec id="S2">
<title>Materials and Methods</title>
<sec id="S2a">
<title>Participants</title>
<p>Samples were collected from individuals residing in Shillong, Meghalaya, located in the North Eastern region of India. The study includes only those individuals whose pedigree can be traced back for three or more consecutive generations. Thus, 196 unrelated adults (130 males, 66 females, mean age: 27.56 ± 9.139 years) from the Indo-Aryan linguistic group were included in the study. Out of the total sample of 196 individuals, 96 were gamblers (49%) and 100 were non-gamblers (51%) and hence were considered as negative control.</p>
</sec>
<sec id="S2b">
<title>Phenotype measures</title>
<p>The gambling phenotype was determined using the Problem Gambling Severity Index (PGSI). The PGSI classifies the gamblers in four categories: non-problem gambler, low-risk gambler, moderate-risk gambler, and problem gambler. The PGSI was submitted to the participants of the study; the answers were recorded and the gamblers were grouped according to the PGSI parameters. In this study, 5.4% were non-problem gamblers, 12% were low-risk gamblers, 39.1% were moderate-risk gamblers, and 43.5% were problem gamblers. The following parameters were assessed: frequency of gambling, amount of money gambled (from 25 to 15,000 Indian Rupees a day), attitude of the participants, etc. For the statistical analysis in this study, participants were grouped into two categories: gamblers and non-gamblers. The non-gamblers, representing the negative control group, reported no lifetime gambling history.</p>
</sec>
<sec id="S2c">
<title>The SNP selection criteria</title>
<p>SNPs with a minor allele frequency (MAF) greater than 0.05 were selected from the Single Nucleotide Polymorphism Database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP">http://www.ncbi.nlm.nih.gov/SNP</ext-link>) of the National Centre for Biotechnology Information. The pairwise tagging method using the linkage disequilibrium r2 threshold of 0.8 by the HaploView Program (<xref ref-type="bibr" rid="B7">Barrett, Fry, Maller, &amp; Daly, 2005</xref>) was used to determine tagging SNPs based on HapMap data to obtain a proper coverage of the GDNF gene. In case of a number of options for tagging SNPs, a reference from previous association studies concerning neuropsychiatric disorders was preferred. We selected the following GDNF SNPs: rs3812047, rs11111, rs3096140, rs1549250, and rs2973033.</p>
<p>Table <xref ref-type="table" rid="T1">1</xref> presents the studied SNPs from the 3′ UTR region of additional candidate genes implicated in addiction and other psychiatric disorders. SNPs selection was preceded by <italic>in silico</italic> searches using several miRNA databases to identify SNPs predicted to alter miRNA binding within the 3′ UTR, therefore, more likely to be a risk factor for the phenotype.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>SNPs investigated with the OpenArray genotyping system</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th colspan="1" rowspan="1">Gene</th>
<th colspan="1" rowspan="1">Gene name</th>
<th colspan="1" rowspan="1">SNP</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">AADAC</td>
<td colspan="1" rowspan="1">Arylacetamide deacetylase</td>
<td colspan="1" rowspan="1">rs1042201</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ACP1</td>
<td colspan="1" rowspan="1">Acid phosphatase 1, soluble</td>
<td colspan="1" rowspan="1">rs6855</td>
</tr>
<tr>
<td colspan="1" rowspan="2">CNR1</td>
<td colspan="1" rowspan="2">Cannabinoid receptor 1</td>
<td colspan="1" rowspan="1">rs4707436</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs806368</td>
</tr>
<tr>
<td colspan="1" rowspan="4">CNTNAP2</td>
<td colspan="1" rowspan="4">Contactin-associated protein-like 2</td>
<td colspan="1" rowspan="1">rs1062072</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs2530310</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs2530311</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs987456</td>
</tr>
<tr>
<td colspan="1" rowspan="2">COMT</td>
<td colspan="1" rowspan="2">Catechol-O-methyltransferase</td>
<td colspan="1" rowspan="1">rs165599</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs165728</td>
</tr>
<tr>
<td colspan="1" rowspan="2">DRD2</td>
<td colspan="1" rowspan="2">Dopamine receptor D2</td>
<td colspan="1" rowspan="1">rs6276</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs6278</td>
</tr>
<tr>
<td colspan="1" rowspan="3">GDNF</td>
<td colspan="1" rowspan="3">Glial cell-derived neurotrophic factor</td>
<td colspan="1" rowspan="1">rs2973051</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs3749692</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs62360370</td>
</tr>
<tr>
<td colspan="1" rowspan="1">HTR2A</td>
<td colspan="1" rowspan="1">5-Hydroxytryptamine receptor 2A</td>
<td colspan="1" rowspan="1">rs3125</td>
</tr>
<tr>
<td colspan="1" rowspan="1">IL1RN</td>
<td colspan="1" rowspan="1">Interleukin 1 receptor antagonist</td>
<td colspan="1" rowspan="1">rs4252041</td>
</tr>
<tr>
<td colspan="1" rowspan="3">IMMP2L</td>
<td colspan="1" rowspan="3">Inner mitochondrial membrane peptidase subunit 2</td>
<td colspan="1" rowspan="1">rs1044729</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs17158195</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs7795011</td>
</tr>
<tr>
<td colspan="1" rowspan="2">LHX6</td>
<td colspan="1" rowspan="2">LIM homeobox 6</td>
<td colspan="1" rowspan="1">rs3750486</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs74370188</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MAOA</td>
<td colspan="1" rowspan="1">monoamine oxidase A</td>
<td colspan="1" rowspan="1">rs3027407</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MEIS1</td>
<td colspan="1" rowspan="1">Meis homeobox 1</td>
<td colspan="1" rowspan="1">rs72824830</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MIR302A</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">rs114318553</td>
</tr>
<tr>
<td colspan="1" rowspan="2">NTN4</td>
<td colspan="1" rowspan="2">Netrin 4</td>
<td colspan="1" rowspan="1">rs1052651</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs8699</td>
</tr>
<tr>
<td colspan="1" rowspan="2">SLC6A3</td>
<td colspan="1" rowspan="2">Solute carrier family 6 member 3</td>
<td colspan="1" rowspan="1">rs11564774</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs7732456</td>
</tr>
<tr>
<td colspan="1" rowspan="2">SLITRK1</td>
<td colspan="1" rowspan="2">SLIT- and NTRK-like family member 1</td>
<td colspan="1" rowspan="1">rs3737193</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs41557622</td>
</tr>
<tr>
<td colspan="1" rowspan="1">TNF</td>
<td colspan="1" rowspan="1">Tumor necrosis factor</td>
<td colspan="1" rowspan="1">rs3093665</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Note.</italic> SNP: single nucleotide polymorphism.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S2d">
<title>Sample preparation and SNP genotyping</title>
<p>Collection of samples and isolation of genomic DNA from buccal swabs were carried out as described previously (<xref ref-type="bibr" rid="B10">Boor et al., 2002</xref>). Concentration of the extracted DNA was measured using NanoDrop™ 1000 (Thermo Fisher Scientific, Waltham, MA, USA).</p>
</sec>
<sec id="S2e">
<title>Genotyping procedure</title>
<sec id="S2e1">
<title>Genotyping of the GDNF gene (real-time PCR)</title>
<p>Genotyping was carried out on the real-time cycler ABI Prism 7300 Real-Time PCR System (Thermo Fisher Scientific). Five SNPs of the GDNF gene located in chromosome position 5p12–p13.1 were genotyped using pre-designed TaqMan<sup>®</sup> kits with FAM and VIC fluorescent probes: rs3812047 (C_27492935_10), rs11111 (C_8813050_1_), rs1549250 (C_11553504_10), rs3096140 (C_1395038_20), and rs2973033 (C_15958567_10).</p>
</sec>
<sec id="S2e2">
<title>OpenArray SNPs genotyping</title>
<p>Genotyping of SNPs mentioned in Table <xref ref-type="table" rid="T1">1</xref> was performed on a TaqMan<sup>®</sup> OpenArray<sup>®</sup> Genotyping System (Thermo Fisher Scientific). The processing of raw data was performed using TaqMan<sup>®</sup> Genotyping Software (Thermo Fisher Scientific). We regenotyped 10% of samples as a quality control step to avoid any batch effects. Out of the 32 SNPs considered for assessment, 27 SNPs were successfully genotyped. Out of the 5 SNPs not included in the statistical analysis, three were non-successfully genotyped (rs41557622 of SLITRK1; rs1062072 and rs2530310 of CNTNAP2) and two were found to be non-polymorphic (rs72824830 of MEIS1 and rs4252041 of IL1R).</p>
</sec>
</sec>
<sec id="S2f">
<title>Statistical analyses</title>
<p>Standard case–control association analysis was performed using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). The <italic>p</italic> values &lt;.05 were considered nominally significant. Correction for multiple testing was made according to the Bonferroni method: the threshold significance was adjusted to <italic>p</italic> &lt; .0015625 where .0015625 = .05/32 (since 5 + 27 = 32 SNPs, genotyped by the two different methods, were used for the final statistical analysis). We applied the most stringent Bonferroni correction for multiple testing to rule out type I errors in null hypothesis testing. In order to estimate the statistical power of our pilot sample, we performed a post-hoc power calculation using the G*Power software (<xref ref-type="bibr" rid="B16">Faul, Erdfelder, Lang, &amp; Buchner, 2007</xref>) to determine the necessary sample size to find significant genetic effects. With a 0.1 effect size (partial eta square value by two groups), by a power set to be at least 0.80, it was determined that 964 participants would be needed in the total sample to detect such an association.</p>
</sec>
<sec id="S2g">
<title>Ethics</title>
<p>The study protocol was approved by the Departmental Research Committee (DRC) of the School of Human Sciences, North Eastern Hill University. Written informed consent was obtained from all participating individuals.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3a">
<title>Real-time PCR genotyping results</title>
<p>MAFs of the GDNF SNPs in this study were compared to other Asian population from the HapMap Project (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>). No significant deviation was observed from the MAFs of Asian population.</p>
<p>A case–control study was conducted to explore possible association of various GDNF gene SNPs with gambling (Table <xref ref-type="table" rid="T2">2</xref>). Table <xref ref-type="table" rid="T3">3</xref> shows the results of χ<sup>2</sup> tests of genotype distribution differences between cases and controls, numbers, and percentages of individuals in each genotype group for (a) non-gamblers (control individuals with no history of gambling) and (b) gamblers. We observed nominally significant differences in case of rs2973033 (<italic>p</italic> = .00027, χ<sup>2</sup> = 16.391, <italic>df</italic> = 2), rs3812047 (<italic>p</italic> = .00314, χ<sup>2</sup> = 8.719, <italic>df</italic> = 1) and rs1549250 (<italic>p</italic> = .045, χ<sup>2</sup> = 6.191, <italic>df</italic> = 2). After correcting for multiple testing, only rs2973033 remained significant (corrected <italic>p</italic> = .00864).</p>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>Location of the real-time PCR-analyzed genetic variants in the vicinity of the GDNF gene</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th colspan="1" rowspan="1">SNP</th>
<th colspan="1" rowspan="1">Location within the gene</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">rs2973033</td>
<td colspan="1" rowspan="1">5′ UTR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs3096140</td>
<td colspan="1" rowspan="1">Intron</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs3812047</td>
<td colspan="1" rowspan="1">Intron</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs1549250</td>
<td colspan="1" rowspan="1">Intron</td>
</tr>
<tr>
<td colspan="1" rowspan="1">rs11111</td>
<td colspan="1" rowspan="1">3′ UTR</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Note.</italic> SNP: single nucleotide polymorphism; PCR: polymerase chain reaction; GDNF: glial cell line-derived neurotrophic factor; UTR: untranslated region.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" orientation="portrait" position="float">
<label>Table 3.</label>
<caption>
<p>The case–control analysis of any form of gambling and GDNF SNPs</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="2" rowspan="1">Non-gamblers</th>
<th colspan="2" rowspan="1">Gamblers</th>
<th colspan="3" rowspan="1"></th>
</tr>
<tr valign="bottom">
<th colspan="1" rowspan="1">GDNF SNP</th>
<th colspan="1" rowspan="1">Genotype</th>
<th colspan="1" rowspan="1">
<italic>N</italic>
</th>
<th colspan="1" rowspan="1">%</th>
<th colspan="1" rowspan="1">
<italic>N</italic>
</th>
<th colspan="1" rowspan="1">%</th>
<th colspan="1" rowspan="1">
<italic>p</italic>
</th>
<th colspan="1" rowspan="1">Corrected <italic>p</italic> value</th>
<th colspan="1" rowspan="1">χ<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="4">rs2973033</td>
<td colspan="1" rowspan="1">CC</td>
<td colspan="1" rowspan="1">40</td>
<td colspan="1" rowspan="1">40</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="4">.00027**</td>
<td colspan="1" rowspan="4">.00864</td>
<td colspan="1" rowspan="4">16.391</td>
</tr>
<tr>
<td colspan="1" rowspan="1">TT</td>
<td colspan="1" rowspan="1">16</td>
<td colspan="1" rowspan="1">16</td>
<td colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">23.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CT</td>
<td colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">58</td>
<td colspan="1" rowspan="1">62.4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">100</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">93</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs3096140</td>
<td colspan="1" rowspan="1">AA</td>
<td colspan="1" rowspan="1">52</td>
<td colspan="1" rowspan="1">60.5</td>
<td colspan="1" rowspan="1">51</td>
<td colspan="1" rowspan="1">56.7</td>
<td colspan="1" rowspan="4">.444</td>
<td colspan="1" rowspan="4">1</td>
<td colspan="1" rowspan="4">1.623</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GG</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">10.5</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">6.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">AG</td>
<td colspan="1" rowspan="1">25</td>
<td colspan="1" rowspan="1">29.1</td>
<td colspan="1" rowspan="1">33</td>
<td colspan="1" rowspan="1">36.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">86</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">90</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs3812047</td>
<td colspan="1" rowspan="1">CC</td>
<td colspan="1" rowspan="1">94</td>
<td colspan="1" rowspan="1">94</td>
<td colspan="1" rowspan="1">75</td>
<td colspan="1" rowspan="1">79.8</td>
<td colspan="1" rowspan="4">.00314*</td>
<td colspan="1" rowspan="4">.10048</td>
<td colspan="1" rowspan="4">8.719</td>
</tr>
<tr>
<td colspan="1" rowspan="1">TT</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CT</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">20.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">100</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">94</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs1549250</td>
<td colspan="1" rowspan="1">AA</td>
<td colspan="1" rowspan="1">18</td>
<td colspan="1" rowspan="1">18</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">13.7</td>
<td colspan="1" rowspan="4">.045*</td>
<td colspan="1" rowspan="4">1</td>
<td colspan="1" rowspan="4">6.191</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CC</td>
<td colspan="1" rowspan="1">51</td>
<td colspan="1" rowspan="1">51</td>
<td colspan="1" rowspan="1">36</td>
<td colspan="1" rowspan="1">37.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1">AC</td>
<td colspan="1" rowspan="1">31</td>
<td colspan="1" rowspan="1">31</td>
<td colspan="1" rowspan="1">46</td>
<td colspan="1" rowspan="1">48.4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">100</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">95</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs11111</td>
<td colspan="1" rowspan="1">CC</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">8.1</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">4.2</td>
<td colspan="1" rowspan="4">.286</td>
<td colspan="1" rowspan="4">1</td>
<td colspan="1" rowspan="4">2.504</td>
</tr>
<tr>
<td colspan="1" rowspan="1">TT</td>
<td colspan="1" rowspan="1">66</td>
<td colspan="1" rowspan="1">66.7</td>
<td colspan="1" rowspan="1">59</td>
<td colspan="1" rowspan="1">62.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CT</td>
<td colspan="1" rowspan="1">25</td>
<td colspan="1" rowspan="1">25.3</td>
<td colspan="1" rowspan="1">32</td>
<td colspan="1" rowspan="1">33.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">99</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">95</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Note.</italic> χ<sup>2</sup>: chi-square value; <italic>p</italic>: <italic>p</italic> value with .05 significance level; SNP: single nucleotide polymorphism; GDNF: glial cell line-derived neurotrophic factor.</p>
<fn>
<p>*Nominally significant (<italic>p</italic> &lt; .05). **Significant after multiple correction (<italic>p</italic> &lt; .001).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In case of GDNF SNP rs1549250, the AA and CC genotypes showed higher frequency in case of the non-gamblers (18% and 51%, respectively) compared to those who gambled (13.7% and 37.9%, respectively). In contrast, the frequency of heterozygote AC was higher in individuals who gambled (48.4%) compared to those who never gambled (31%). In case of GDNF SNP rs3812047, the frequency of the CT genotype was higher in gamblers (20.2%) than non-gamblers (6%), suggesting a protective role for the more common CC genotype (the TT homozygous genotype was absent from both groups in our sample). Nevertheless, the above results did not survive Bonferroni correction for multiple testing.</p>
<p>When looking at rs2973033, we observed that the frequency of CT and TT genotypes is higher in case of gamblers (62.4% and 23.7%, respectively) compared to non-gamblers (44% and 16%, respectively). The result suggests that the CT and TT genotypes might serve as risk factors, whereas the CC genotype could be protective against gambling (<italic>p</italic> = .00027, χ<sup>2</sup> = 16.391, <italic>df</italic> = 2). The association of rs2979033 with gambling remained statistically significant after Bonferroni correction for multiple testing (corrected <italic>p</italic> = .00864).</p>
</sec>
<sec id="S3b">
<title>OpenArray genotyping results</title>
<p>Table <xref ref-type="table" rid="T4">4</xref> shows the top hits (<italic>p</italic> &lt; .05) of the case–control analysis involving the 3′ UTR SNPs genotyped on the OpenArray platform; detailed results of the successfully genotyped SNPs are available in Supplementary Table S1. SNP rs74370188 in the LHX6 gene showed a nominally significant (<italic>p</italic> = .01571, χ<sup>2</sup> = 5.834, <italic>df</italic> = 1) association in the χ<sup>2</sup> test. The frequency of the most prevalent GG genotype is higher in non-gamblers (78.0%) than in gamblers (61.7%). However, rs74370188 does not survive the Bonferroni correction for multiple testing.</p>
<table-wrap id="T4" orientation="portrait" position="float">
<label>Table 4.</label>
<caption>
<p>The top two SNPs (<italic>p</italic> &lt; .05) of the case–control analysis of any form of gambling and SNPs in 3′ UTR: OpenArray results</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="2" rowspan="1">Non-gamblers</th>
<th colspan="2" rowspan="1">Gamblers</th>
<th colspan="4" rowspan="1"></th>
</tr>
<tr valign="bottom">
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1">Genotype</th>
<th colspan="1" rowspan="1">
<italic>N</italic>
</th>
<th colspan="1" rowspan="1">%</th>
<th colspan="1" rowspan="1">
<italic>N</italic>
</th>
<th colspan="1" rowspan="1">%</th>
<th colspan="1" rowspan="1">
<italic>p</italic>
</th>
<th colspan="1" rowspan="1">Corrected <italic>p</italic> value</th>
<th colspan="1" rowspan="1">χ<sup>2</sup></th>
<th colspan="1" rowspan="1">OR</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="10" rowspan="1">
<italic>CNTNAP2</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs2530311</td>
<td colspan="1" rowspan="1">AA</td>
<td colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">23.9</td>
<td colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">47.7</td>
<td colspan="1" rowspan="4">.00140**</td>
<td colspan="1" rowspan="4">.0448</td>
<td colspan="1" rowspan="4">13.132</td>
<td colspan="1" rowspan="4">NA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GG</td>
<td colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">21.6</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">8.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">AG</td>
<td colspan="1" rowspan="1">48</td>
<td colspan="1" rowspan="1">54.5</td>
<td colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">44.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">88</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">86</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="10" rowspan="1">
<italic>LHX6</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="4">rs74370188</td>
<td colspan="1" rowspan="1">AA</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="4">.01571*</td>
<td colspan="1" rowspan="4">.5072</td>
<td colspan="1" rowspan="4">5.834</td>
<td colspan="1" rowspan="4">0.454</td>
</tr>
<tr>
<td colspan="1" rowspan="1">GG</td>
<td colspan="1" rowspan="1">71</td>
<td colspan="1" rowspan="1">78</td>
<td colspan="1" rowspan="1">58</td>
<td colspan="1" rowspan="1">61.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">AG</td>
<td colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">36</td>
<td colspan="1" rowspan="1">38.3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">91</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">94</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Note.</italic> χ<sup>2</sup>: Chi-square value; OR: odds ratio; UTR: untranslated region; SNP: single nucleotide polymorphism; NA: not applicable; <italic>p</italic>: <italic>p</italic> value with .05 significance level.</p>
<fn>
<p>*Nominally significant (<italic>p</italic> &lt; .05). **Significant after multiple correction (<italic>p</italic> &lt; .001).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In the case of rs2530311 located in CNTNAP2 gene, we observed a significant association (<italic>p</italic> = .00140, χ<sup>2</sup> = 13.132, <italic>df</italic> = 2) in the χ<sup>2</sup> test, which withstands correction for multiple testing (corrected <italic>p</italic> = .0448). The frequency of the AA genotype of rs2530311 is higher in case of gamblers (47.7%) compared to non-gamblers (23.9%). Thus, the AA genotype seems to be the risk factor for gambling.</p>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>This study was conducted on a population of gamblers involved in a local archery game in Meghalaya, India. The traditional sport, commonly known as “teer,” has gained widespread popularity among locals of Shillong in part due to the high odds offered by the organizers, allowing winners to take home 80 times the sum that was gambled.</p>
<p>Our case–control genetic analysis identified two significant associations between gambling and the GDNF gene SNP rs2973033 (<italic>p</italic> = .00864, χ<sup>2</sup> = 16.391, <italic>df</italic> = 2) and the CNTNAP2 gene SNP rs2530311 (<italic>p</italic> = .0448, χ<sup>2</sup> = 13.132, <italic>df</italic> = 2) after correction for multiple testing.</p>
<p>GDNF is a well-studied gene associated with addiction and plays a role in several processes including drug reward, drug self-administration, relapse, and abstinence (<xref ref-type="bibr" rid="B17">Ghitza et al., 2010</xref>; <xref ref-type="bibr" rid="B52">Wise, 2004</xref>). The gene encodes a secreted ligand of the transforming growth factor-beta (TGF-β) receptor superfamily of proteins. Upon ligand binding to various TGF-β receptors, transcription factors of the SMAD family are recruited and activated, resulting in gene expression changes. GDNF is involved in the growth, survival, and morphological differentiation of dopaminergic neurons during development as well as enhanced high-affinity uptake of dopamine in rat embryonic midbrain cells (<xref ref-type="bibr" rid="B32">Lin, Doherty, Lile, Bektesh, &amp; Collins, 1993</xref>). The role of GDNF in reward mechanisms has been shown in animal model studies with drugs like cocaine, methamphetamine, and alcohol (<xref ref-type="bibr" rid="B17">Ghitza et al., 2010</xref>). Moreover, external injection of GDNF in rats was shown to reduce the impact of dopamine depletion observed during drug abstinence (<xref ref-type="bibr" rid="B6">Barak, Carnicella, Yowell, &amp; Ron, 2011</xref>). A GDNF knockout study in mice has also shown increased sensitivity for alcohol in case of heterozygotes compared to wild-type homozygotes, thus confirming the role of endogenous GDNF in reducing the rewarding effects of ethanol (<xref ref-type="bibr" rid="B12">Carnicella, Ahmadiantehrani, Janak, &amp; Ron, 2009</xref>). In a previous study conducted by our group, strong association was observed between GDNF SNPs rs3812047 and rs11111 with nicotine and betel quid use (unpublished data).</p>
<p>In this study, we report a significant association of rs2973033 in GDNF with game-based gambling. Our results confirm the role of GDNF in addiction, and to our knowledge, this is the first study to show association of GDNF gene polymorphisms with gambling as a type of behavioral addiction.</p>
<p>The CNTNAP2 gene codes for a neuronal transmembrane protein belonging to the neurexin superfamily involved in communication between neuronal cells (<xref ref-type="bibr" rid="B14">Condro &amp; White, 2014</xref>). This protein is also involved in localization of potassium channels within differentiating axons (<xref ref-type="bibr" rid="B37">Poliak et al., 1999</xref>). The gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. Due to its large extent, it is likely a target for structural rearrangements, including copy number variations, translocations, altered transcription factor binding, and also epigenetic modifications, including miRNA regulation. The CNTNAP2 gene has been implicated in several neurodevelopmental disorders. Due to a translocation affecting the coding region of the gene, it was found to be associated with Gilles de la Tourette syndrome, intellectual disability, and obsessive–compulsive disorder (<xref ref-type="bibr" rid="B49">Verkerk et al., 2003</xref>). Other cognitive disorders, such as schizophrenia, epilepsy, autism, and attention-deficit hyperactivity disorder, were also linked to disruptions in CNTNAP2 gene (<xref ref-type="bibr" rid="B39">Rodenas-Cuadrado, Ho, &amp; Vernes, 2014</xref>). SNP variants of this gene were also linked to various complex neurological disorders including autism (<xref ref-type="bibr" rid="B2">Alarcon et al., 2008</xref>; <xref ref-type="bibr" rid="B4">Arking et al., 2008</xref>; <xref ref-type="bibr" rid="B47">Strauss et al., 2006</xref>), schizophrenia, and depression (<xref ref-type="bibr" rid="B27">Ji et al., 2013</xref>). CNTNAP2 gene was previously identified in alcohol addiction (<xref ref-type="bibr" rid="B44">Song &amp; Zhang, 2014</xref>). The study used a new computational method, tree-based analysis of rare variants, to investigate the effect of rare variants in complex disorders. The authors suggested that 97 rare variants of the CNTNAP2 gene could be protective against alcohol addiction in women. In this study, we found that the common variant rs2530311 of the CNTNAP2 gene is associated with gambling, thus corroborating the involvement of this gene in the addiction behavior.</p>
<p>The main limitation of the study is the relatively small sample size. However, this is a pilot study performed with a very unique, culturally distinct phenotype and even this collection has proven to be a great challenge. Thus, our final sample consisted of 196 participants, on which the exploratory genetic association analysis was conducted.</p>
<p>In conclusion, to our knowledge, this is the first study reporting a direct link between CNTNAP2 and game-based gambling. This study further confirms the role of GDNF in addiction, while it is the first study to show the association of GDNF polymorphism with gambling as a type of behavioral addiction.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would particularly like to thank all participants who took part in this study. They would also like to thank Ms. Cynthia Hunn for her kind assistance in editing the manuscript.</p>
</ack>
<sec id="S5" sec-type="conflict of interest">
<title>Authors’ contribution</title>
<p>AD and BL collected the samples. AD, LP, AV, and CB performed the DNA extraction and genotyping. AD, LP, AV, and EK carried out the statistical analyses. All authors have contributed to the final draft of the manuscript. AD and LP contributed equally to this work.</p>
</sec>
<sec id="S6" sec-type="conflict of interest">
<title>Conflict of interest</title>
<p>The authors declare no conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abelson</surname><given-names>J. F.</given-names></name><name><surname>Kwan</surname><given-names>K. Y.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Baek</surname><given-names>D. Y.</given-names></name><name><surname>Stillman</surname><given-names>A. A.</given-names></name><name><surname>Morgan</surname><given-names>T. M.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Rasin</surname><given-names>M. R.</given-names></name><name><surname>Gunel</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>N. R.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Guez</surname><given-names>D. H.</given-names></name><name><surname>Spertus</surname><given-names>J. A.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><name><surname>Dure</surname><given-names>L. S.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Singer</surname><given-names>H. S.</given-names></name><name><surname>Gilbert</surname><given-names>D. L.</given-names></name><name><surname>Farhi</surname><given-names>A.</given-names></name><name><surname>Louvi</surname><given-names>A.</given-names></name><name><surname>Lifton</surname><given-names>R. P.</given-names></name><name><surname>Sestan</surname><given-names>N.</given-names></name><name><surname>State</surname><given-names>M. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Sequence variants in SLITRK1 are associated with Tourette’s syndrome</article-title>. <source/>Science,
<volume>310</volume>(<issue>5746</issue>), <fpage>317</fpage>–<lpage>320</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1116502</pub-id><pub-id pub-id-type="pmid">16224024</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon</surname><given-names>M.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Stone</surname><given-names>J. L.</given-names></name><name><surname>Duvall</surname><given-names>J. A.</given-names></name><name><surname>Perederiy</surname><given-names>J. V.</given-names></name><name><surname>Bomar</surname><given-names>J. M.</given-names></name><name><surname>Sebat</surname><given-names>J.</given-names></name><name><surname>Wigler</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>C. L.</given-names></name><name><surname>Ledbetter</surname><given-names>D. H.</given-names></name><name><surname>Nelson</surname><given-names>S. F.</given-names></name><name><surname>Cantor</surname><given-names>R. M.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene</article-title>. <source/>American Journal of Human Genetics,
<volume>82</volume>(<issue>1</issue>), <fpage>150</fpage>–<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.005</pub-id><pub-id pub-id-type="pmid">18179893</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. (<year>2013</year>). <source/>Diagnostic and statistical manual of mental disorders (<edition>5th ed.</edition>). <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>.</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Cutler</surname><given-names>D. J.</given-names></name><name><surname>Brune</surname><given-names>C. W.</given-names></name><name><surname>Teslovich</surname><given-names>T. M.</given-names></name><name><surname>West</surname><given-names>K.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Rea</surname><given-names>A.</given-names></name><name><surname>Guy</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Cook</surname><given-names>E. H.</given-names></name><name><surname>Chakravarti</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism</article-title>. <source/>American Journal of Human Genetics,
<volume>82</volume>(<issue>1</issue>), <fpage>160</fpage>–<lpage>164</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.015</pub-id><pub-id pub-id-type="pmid">18179894</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bali</surname><given-names>P.</given-names></name><name><surname>Kenny</surname><given-names>P. J.</given-names></name></person-group> (<year>2013</year>). <article-title>MicroRNAs and drug addiction</article-title>. <source/>Frontiers in Genetics,
<volume>4,</volume>
<fpage>43</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fgene.2013.00043</pub-id><pub-id pub-id-type="pmid">23717324</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barak</surname><given-names>S.</given-names></name><name><surname>Carnicella</surname><given-names>S.</given-names></name><name><surname>Yowell</surname><given-names>Q. V.</given-names></name><name><surname>Ron</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: Implications for alcohol reward and seeking</article-title>. <source/>Journal of Neuroscience,
<volume>31</volume>(<issue>27</issue>), <fpage>9885</fpage>–<lpage>9894</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1750-11.2011</pub-id><pub-id pub-id-type="pmid">21734280</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>J. C.</given-names></name><name><surname>Fry</surname><given-names>B.</given-names></name><name><surname>Maller</surname><given-names>J.</given-names></name><name><surname>Daly</surname><given-names>M. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Haploview: Analysis and visualization of LD and haplotype maps</article-title>. <source/>Bioinformatics,
<volume>21</volume>(<issue>2</issue>), <fpage>263</fpage>–<lpage>265</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertelsen</surname><given-names>B.</given-names></name><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Jensen</surname><given-names>L. R.</given-names></name><name><surname>Melchior</surname><given-names>L.</given-names></name><name><surname>Debes</surname><given-names>N. M.</given-names></name><name><surname>Groth</surname><given-names>C.</given-names></name><name><surname>Skov</surname><given-names>L.</given-names></name><name><surname>Werge</surname><given-names>T.</given-names></name><name><surname>Karagiannidis</surname><given-names>I.</given-names></name><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Barta</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Association of AADAC deletion and Gilles de la Tourette Syndrome in a large European cohort</article-title>. <source/>Biological Psychiatry,
<volume>79</volume>(<issue>5</issue>), <fpage>383</fpage>–<lpage>391</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.027</pub-id><pub-id pub-id-type="pmid">26444075</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beveridge</surname><given-names>N. J.</given-names></name><name><surname>Gardiner</surname><given-names>E.</given-names></name><name><surname>Carroll</surname><given-names>A. P.</given-names></name><name><surname>Tooney</surname><given-names>P. A.</given-names></name><name><surname>Cairns</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Schizophrenia is associated with an increase in cortical microRNA biogenesis</article-title>. <source/>Molecular Psychiatry,
<volume>15</volume>(<issue>12</issue>), <fpage>1176</fpage>–<lpage>1189</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2009.84</pub-id><pub-id pub-id-type="pmid">19721432</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boor</surname><given-names>K.</given-names></name><name><surname>Ronai</surname><given-names>Z.</given-names></name><name><surname>Nemoda</surname><given-names>Z.</given-names></name><name><surname>Gaszner</surname><given-names>P.</given-names></name><name><surname>Sasvari-Szekely</surname><given-names>M.</given-names></name><name><surname>Guttman</surname><given-names>A.</given-names></name><name><surname>Kalasz</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients</article-title>. <source/>Current Medicinal Chemistry,
<volume>9</volume>(<issue>8</issue>), <fpage>793</fpage>–<lpage>797</lpage>. doi:<pub-id pub-id-type="doi">10.2174/0929867024606821</pub-id><pub-id pub-id-type="pmid">11966444</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X. T.</given-names></name><name><surname>Han</surname><given-names>S. Z.</given-names></name><name><surname>Zhang</surname><given-names>C. K.</given-names></name><name><surname>Liu</surname><given-names>Z. Z.</given-names></name><name><surname>Li</surname><given-names>D. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Association of the HTR2A gene with alcohol and heroin abuse</article-title>. <source/>Human Genetics,
<volume>133</volume>(<issue>3</issue>), <fpage>357</fpage>–<lpage>365</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00439-013-1388-y</pub-id><pub-id pub-id-type="pmid">24178752</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnicella</surname><given-names>S.</given-names></name><name><surname>Ahmadiantehrani</surname><given-names>S.</given-names></name><name><surname>Janak</surname><given-names>P. H.</given-names></name><name><surname>Ron</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence</article-title>. <source/>Alcoholism-Clinical and Experimental Research,
<volume>33</volume>(<issue>6</issue>), <fpage>1012</fpage>–<lpage>1024</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1530-0277.2009.00922.x</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>T. K.</given-names></name><name><surname>Bloch</surname><given-names>P. J.</given-names></name><name><surname>Ambrose-Lanci</surname><given-names>L. M.</given-names></name><name><surname>Ferraro</surname><given-names>T. N.</given-names></name><name><surname>Berrettini</surname><given-names>W. H.</given-names></name><name><surname>Kampman</surname><given-names>K. M.</given-names></name><name><surname>Dackis</surname><given-names>C. A.</given-names></name><name><surname>Pettinati</surname><given-names>H. M.</given-names></name><name><surname>O’Brien</surname><given-names>C. P.</given-names></name><name><surname>Oslin</surname><given-names>D. W.</given-names></name><name><surname>Lohoff</surname><given-names>F. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: Confirmation in an independent sample and meta-analysis</article-title>. <source/>Addiction Biology,
<volume>18</volume>(<issue>4</issue>), <fpage>702</fpage>–<lpage>708</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1369-1600.2011.00346.x</pub-id><pub-id pub-id-type="pmid">21790903</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condro</surname><given-names>M. C.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Distribution of language-related Cntnap2 protein in neural circuits critical for vocal learning</article-title>. <source/>The Journal of Comparative Neurology,
<volume>522</volume>(<issue>1</issue>), <fpage>169</fpage>–<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.23394</pub-id><pub-id pub-id-type="pmid">23818387</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagundo</surname><given-names>A. B.</given-names></name><name><surname>Fernandez-Aranda</surname><given-names>F.</given-names></name><name><surname>de la Torre</surname><given-names>R.</given-names></name><name><surname>Verdejo-Garcia</surname><given-names>A.</given-names></name><name><surname>Granero</surname><given-names>R.</given-names></name><name><surname>Penelo</surname><given-names>E.</given-names></name><name><surname>Gené</surname><given-names>M.</given-names></name><name><surname>Barrot</surname><given-names>C.</given-names></name><name><surname>Sánchez</surname><given-names>C.</given-names></name><name><surname>Alvarez-Moya</surname><given-names>E.</given-names></name><name><surname>Ochoa</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers</article-title>. <source/>Journal of Psychopharmacology,
<volume>28</volume>(<issue>12</issue>), <fpage>1170</fpage>–<lpage>1177</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0269881114551079</pub-id><pub-id pub-id-type="pmid">25237117</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F.</given-names></name><name><surname>Erdfelder</surname><given-names>E.</given-names></name><name><surname>Lang</surname><given-names>A. G.</given-names></name><name><surname>Buchner</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title>. <source/>Behavior Research Methods,
<volume>39</volume>(<issue>2</issue>), <fpage>175</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.3758/BF03193146</pub-id><pub-id pub-id-type="pmid">17695343</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghitza</surname><given-names>U. E.</given-names></name><name><surname>Zhai</surname><given-names>H. F.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Airavaara</surname><given-names>M.</given-names></name><name><surname>Shaham</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of BDNF and GDNF in drug reward and relapse: A review</article-title>. <source/>Neuroscience and Biobehavioral Reviews,
<volume>35</volume>(<issue>2</issue>), <fpage>157</fpage>–<lpage>171</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2009.11.009</pub-id><pub-id pub-id-type="pmid">19914287</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>J. E.</given-names></name><name><surname>Leppink</surname><given-names>E. W.</given-names></name><name><surname>Redden</surname><given-names>S. A.</given-names></name><name><surname>Odlaug</surname><given-names>B. L.</given-names></name><name><surname>Chamberlain</surname><given-names>S. R.</given-names></name></person-group> (<year>2015</year>). <article-title>COMT genotype, gambling activity, and cognition</article-title>. <source/>Journal of Psychiatric Research,
<volume>68,</volume>
<fpage>371</fpage>–<lpage>376</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.04.029</pub-id><pub-id pub-id-type="pmid">26028545</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>J. E.</given-names></name><name><surname>Potenza</surname><given-names>M. N.</given-names></name><name><surname>Weinstein</surname><given-names>A.</given-names></name><name><surname>Gorelick</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Introduction to behavioral addictions</article-title>. <source/>American Journal of Drug and Alcohol Abuse,
<volume>36</volume>(<issue>5</issue>), <fpage>233</fpage>–<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.3109/00952990.2010.491884</pub-id><pub-id pub-id-type="pmid">20560821</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillot</surname><given-names>C. R.</given-names></name><name><surname>Fanning</surname><given-names>J. R.</given-names></name><name><surname>Liang</surname><given-names>T. B.</given-names></name><name><surname>Berman</surname><given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>COMT associations with disordered gambling and drinking measures</article-title>. <source/>Journal of Gambling Studies,
<volume>31</volume>(<issue>2</issue>), <fpage>513</fpage>–<lpage>524</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10899-013-9434-1</pub-id><pub-id pub-id-type="pmid">24390676</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyollai</surname><given-names>A.</given-names></name><name><surname>Griffiths</surname><given-names>M. D.</given-names></name><name><surname>Barta</surname><given-names>C.</given-names></name><name><surname>Vereczkei</surname><given-names>A.</given-names></name><name><surname>Urban</surname><given-names>R.</given-names></name><name><surname>Kun</surname><given-names>B.</given-names></name><name><surname>Kokonyei</surname><given-names>G.</given-names></name><name><surname>Székely</surname><given-names>A.</given-names></name><name><surname>Sasvári-Székely</surname><given-names>M.</given-names></name><name><surname>Blum</surname><given-names>K.</given-names></name><name><surname>Demetrovics</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>The genetics of problem and pathological gambling: A systematic review</article-title>. <source/>Current Pharmaceutical Design,
<volume>20</volume>(<issue>25</issue>), <fpage>3993</fpage>–<lpage>3999</lpage>. doi:<pub-id pub-id-type="doi">10.2174/13816128113199990626</pub-id><pub-id pub-id-type="pmid">24001288</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerschlag</surname><given-names>A. R.</given-names></name><name><surname>Stringer</surname><given-names>S.</given-names></name><name><surname>de Leeuw</surname><given-names>C. A.</given-names></name><name><surname>Sniekers</surname><given-names>S.</given-names></name><name><surname>Taskesen</surname><given-names>E.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Blanken</surname><given-names>T. F.</given-names></name><name><surname>Dekker</surname><given-names>K.</given-names></name><name><surname>Te Lindert</surname><given-names>B. H.</given-names></name><name><surname>Wassing</surname><given-names>R.</given-names></name><name><surname>Jonsdottir</surname><given-names>I.</given-names></name></person-group> (<year>2017</year>). <article-title>Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits</article-title>. <source/>Nature Genetics,
<volume>49</volume>(<issue>11</issue>), <fpage>1584</fpage>–<lpage>1592</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.3888</pub-id><pub-id pub-id-type="pmid">28604731</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heberlein</surname><given-names>A.</given-names></name><name><surname>Kaser</surname><given-names>M.</given-names></name><name><surname>Lichtinghagen</surname><given-names>R.</given-names></name><name><surname>Rhein</surname><given-names>M.</given-names></name><name><surname>Lenz</surname><given-names>B.</given-names></name><name><surname>Kornhuber</surname><given-names>J.</given-names></name><name><surname>Bleich</surname><given-names>S.</given-names></name><name><surname>Hillemacher</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>TNF-alpha and IL-6 serum levels: Neurobiological markers of alcohol consumption in alcohol-dependent patients?</article-title>
<source/>Alcohol,
<volume>48</volume>(<issue>7</issue>), <fpage>671</fpage>–<lpage>676</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.alcohol.2014.08.003</pub-id><pub-id pub-id-type="pmid">25262503</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillemacher</surname><given-names>T.</given-names></name><name><surname>Bleich</surname><given-names>S.</given-names></name><name><surname>Frieling</surname><given-names>H.</given-names></name><name><surname>Buchholz</surname><given-names>V.</given-names></name><name><surname>Hussein</surname><given-names>R.</given-names></name><name><surname>Meyer</surname><given-names>C.</given-names></name><name><surname>Meyer</surname><given-names>C.</given-names></name><name><surname>John</surname><given-names>U.</given-names></name><name><surname>Bischof</surname><given-names>A.</given-names></name><name><surname>Rumpf</surname><given-names>H. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Dopamine-receptor 2 gene-methylation and gambling behavior in relation to impulsivity</article-title>. <source/>Psychiatry Research,
<volume>239,</volume>
<fpage>154</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2016.03.021</pub-id><pub-id pub-id-type="pmid">27137978</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibanez</surname><given-names>A.</given-names></name><name><surname>Perez de Castro</surname><given-names>I.</given-names></name><name><surname>Fernandez-Piqueras</surname><given-names>J.</given-names></name><name><surname>Blanco</surname><given-names>C.</given-names></name><name><surname>Saiz-Ruiz</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes</article-title>. <source/>Molecular Psychiatry,
<volume>5</volume>(<issue>1</issue>), <fpage>105</fpage>–<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.mp.4000654</pub-id><pub-id pub-id-type="pmid">10673777</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Icick</surname><given-names>R.</given-names></name><name><surname>Peoc’h</surname><given-names>K.</given-names></name><name><surname>Karsinti</surname><given-names>E.</given-names></name><name><surname>Ksouda</surname><given-names>K.</given-names></name><name><surname>Hajj</surname><given-names>A.</given-names></name><name><surname>Bloch</surname><given-names>V.</given-names></name><name><surname>Prince</surname><given-names>N.</given-names></name><name><surname>Mouly</surname><given-names>S.</given-names></name><name><surname>Bellivier</surname><given-names>F.</given-names></name><name><surname>Lépine</surname><given-names>J. P.</given-names></name><name><surname>Laplanche</surname><given-names>J. L.</given-names></name></person-group> (<year>2015</year>). <article-title>A Cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients</article-title>. <source/>American Journal on Addictions,
<volume>24</volume>(<issue>7</issue>), <fpage>613</fpage>–<lpage>620</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ajad.12273</pub-id><pub-id pub-id-type="pmid">26331953</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>H.</given-names></name><name><surname>Ju</surname><given-names>K.</given-names></name><name><surname>Wen</surname><given-names>Z.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>An</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population</article-title>. <source/>Psychiatry Research,
<volume>207</volume>(<issue>3</issue>), <fpage>225</fpage>–<lpage>228</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2012.09.024</pub-id><pub-id pub-id-type="pmid">23123147</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joutsa</surname><given-names>J.</given-names></name><name><surname>Hirvonen</surname><given-names>M. M.</given-names></name><name><surname>Arponen</surname><given-names>E.</given-names></name><name><surname>Hietala</surname><given-names>J.</given-names></name><name><surname>Kaasinen</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>DRD2-related TaqIA genotype is associated with dopamine release during a gambling task</article-title>. <source/>Journal of Addiction Medicine,
<volume>8</volume>(<issue>4</issue>), <fpage>294</fpage>–<lpage>295</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ADM.0000000000000037</pub-id><pub-id pub-id-type="pmid">25089954</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapelski</surname><given-names>P.</given-names></name><name><surname>Skibinska</surname><given-names>M.</given-names></name><name><surname>Maciukiewicz</surname><given-names>M.</given-names></name><name><surname>Pawlak</surname><given-names>J.</given-names></name><name><surname>Dmitrzak-Weglarz</surname><given-names>M.</given-names></name><name><surname>Szczepankiewicz</surname><given-names>A.</given-names></name><name><surname>Zaremba</surname><given-names>D.</given-names></name><name><surname>Twarowska-Hauser</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>An association between functional polymorphisms of the interleukin 1 gene complex and schizophrenia using transmission disequilibrium test</article-title>. <source/>Archivum Immunologiae et Therapiae Experimentalis,
<volume>64</volume>(<issue>Suppl. 1</issue>), <fpage>161</fpage>–<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00005-016-0434-6</pub-id><pub-id pub-id-type="pmid">28083609</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kordi-Tamandani</surname><given-names>D. M.</given-names></name><name><surname>Tajoddini</surname><given-names>S.</given-names></name><name><surname>Salimi</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Promoter methylation and BDNF and DAT1 gene expression profiles in patients with drug addiction</article-title>. <source/>Pathobiology,
<volume>82</volume>(<issue>2</issue>), <fpage>94</fpage>–<lpage>99</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000430465</pub-id><pub-id pub-id-type="pmid">26160290</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotyuk</surname><given-names>E.</given-names></name><name><surname>Nemeth</surname><given-names>N.</given-names></name><name><surname>Ronai</surname><given-names>Z.</given-names></name><name><surname>Demetrovics</surname><given-names>Z.</given-names></name><name><surname>Sasvari-Szekely</surname><given-names>M.</given-names></name><name><surname>Szekely</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor</article-title>. <source/>Journal of Genetics,
<volume>95</volume>(<issue>4</issue>), <fpage>811</fpage>–<lpage>818</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12041-016-0701-7</pub-id><pub-id pub-id-type="pmid">27994179</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L. F.</given-names></name><name><surname>Doherty</surname><given-names>D. H.</given-names></name><name><surname>Lile</surname><given-names>J. D.</given-names></name><name><surname>Bektesh</surname><given-names>S.</given-names></name><name><surname>Collins</surname><given-names>F.</given-names></name></person-group> (<year>1993</year>). <article-title>GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons</article-title>. <source/>Science,
<volume>260</volume>(<issue>5111</issue>), <fpage>1130</fpage>–<lpage>1132</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.8493557</pub-id><pub-id pub-id-type="pmid">8493557</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname><given-names>P.</given-names></name><name><surname>Stylianopoulou</surname><given-names>E.</given-names></name><name><surname>Karagiannidis</surname><given-names>I.</given-names></name><name><surname>Rizzo</surname><given-names>R.</given-names></name><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Wolanczyk</surname><given-names>T.</given-names></name><name><surname>Hebebrand</surname><given-names>J.</given-names></name><name><surname>Nöthen</surname><given-names>M. M.</given-names></name><name><surname>Lehmkuhl</surname><given-names>G.</given-names></name><name><surname>Farkas</surname><given-names>L.</given-names></name><name><surname>Nagy</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome</article-title>. <source/>Genes, Brain, and Behavior,
<volume>11</volume>(<issue>4</issue>), <fpage>444</fpage>–<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1601-183X.2012.00778.x</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Gerber</surname><given-names>G.</given-names></name><name><surname>Evans</surname><given-names>P.</given-names></name><name><surname>Tsetsos</surname><given-names>F.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><name><surname>Karagiannidis</surname><given-names>I.</given-names></name><name><surname>Chaponis</surname><given-names>J.</given-names></name><name><surname>Gamazon</surname><given-names>E.</given-names></name><name><surname>Mueller-Vahl</surname><given-names>K.</given-names></name><name><surname>Stuhrmann</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetic association signal near NTN4 in Tourette syndrome</article-title>. <source/>Annals of Neurology,
<volume>76</volume>(<issue>2</issue>), <fpage>310</fpage>–<lpage>315</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24215</pub-id><pub-id pub-id-type="pmid">25042818</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Rubio</surname><given-names>G.</given-names></name><name><surname>Ramirez-Venegas</surname><given-names>A.</given-names></name><name><surname>Diaz</surname><given-names>V. N.</given-names></name><name><surname>Gomez</surname><given-names>L. G.</given-names></name><name><surname>Fabian</surname><given-names>K. E.</given-names></name><name><surname>Carmona</surname><given-names>S. G.</given-names></name><name><surname>López-Flores</surname><given-names>L. A.</given-names></name><name><surname>Ambrocio-Ortiz</surname><given-names>E.</given-names></name><name><surname>Romero</surname><given-names>R. C.</given-names></name><name><surname>Alcantar-Ayala</surname><given-names>N.</given-names></name><name><surname>Sansores</surname><given-names>R. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Polymorphisms in HTR2A and DRD4 predispose to smoking and smoking quantity</article-title>. <source/>PLoS One,
<volume>12</volume>(<issue>1</issue>), <fpage>e0170019</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0170019</pub-id><pub-id pub-id-type="pmid">28103253</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petek</surname><given-names>E.</given-names></name><name><surname>Windpassinger</surname><given-names>C.</given-names></name><name><surname>Vincent</surname><given-names>J. B.</given-names></name><name><surname>Cheung</surname><given-names>J.</given-names></name><name><surname>Boright</surname><given-names>A. P.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name><name><surname>Kroisel</surname><given-names>P. M.</given-names></name><name><surname>Wagner</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome</article-title>. <source/>American Journal of Human Genetics,
<volume>68</volume>(<issue>4</issue>), <fpage>848</fpage>–<lpage>858</lpage>. doi:<pub-id pub-id-type="doi">10.1086/319523</pub-id><pub-id pub-id-type="pmid">11254443</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poliak</surname><given-names>S.</given-names></name><name><surname>Gollan</surname><given-names>L.</given-names></name><name><surname>Martinez</surname><given-names>R.</given-names></name><name><surname>Custer</surname><given-names>A.</given-names></name><name><surname>Einheber</surname><given-names>S.</given-names></name><name><surname>Salzer</surname><given-names>J. L.</given-names></name><name><surname>Trimmer</surname><given-names>J. S.</given-names></name><name><surname>Shrager</surname><given-names>P.</given-names></name><name><surname>Peles</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels</article-title>. <source/>Neuron,
<volume>24</volume>(<issue>4</issue>), <fpage>1037</fpage>–<lpage>1047</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81049-1</pub-id><pub-id pub-id-type="pmid">10624965</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>T. W.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Behavioral addictions</article-title>. <source/>Current Opinion in Neurobiology,
<volume>30,</volume>
<fpage>66</fpage>–<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.conb.2014.09.005</pub-id><pub-id pub-id-type="pmid">25262209</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodenas-Cuadrado</surname><given-names>P.</given-names></name><name><surname>Ho</surname><given-names>J.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Shining a light on CNTNAP2: Complex functions to complex disorders</article-title>. <source/>European Journal of Human Genetics,
<volume>22</volume>(<issue>2</issue>), <fpage>171</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ejhg.2013.100</pub-id><pub-id pub-id-type="pmid">23714751</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D.</given-names></name><name><surname>Janak</surname><given-names>P. H.</given-names></name></person-group> (<year>2005</year>). <article-title>GDNF and addiction</article-title>. <source/>Reviews in the Neurosciences,
<volume>16</volume>(<issue>4</issue>), <fpage>277</fpage>–<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1515/REVNEURO.2005.16.4.277</pub-id><pub-id pub-id-type="pmid">16519005</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>H. J.</given-names></name><name><surname>Hall</surname><given-names>M. N.</given-names></name><name><surname>Vander Bilt</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Estimating the prevalence of disordered gambling behavior in the United States and Canada: A research synthesis</article-title>. <source/>American Journal of Public Health,
<volume>89</volume>(<issue>9</issue>), <fpage>1369</fpage>–<lpage>1376</lpage>. doi:<pub-id pub-id-type="doi">10.2105/AJPH.89.9.1369</pub-id><pub-id pub-id-type="pmid">10474555</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>M. S.</given-names></name><name><surname>Soga</surname><given-names>T.</given-names></name><name><surname>Pandy</surname><given-names>V.</given-names></name><name><surname>Wu</surname><given-names>Y. S.</given-names></name><name><surname>Parhar</surname><given-names>I. S.</given-names></name><name><surname>Mohamed</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens</article-title>. <source/>Metabolic Brain Disease,
<volume>32</volume>(<issue>6</issue>), <fpage>1767</fpage>–<lpage>1783</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11011-017-0061-x</pub-id><pub-id pub-id-type="pmid">28681200</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A. C. W.</given-names></name><name><surname>Kenny</surname><given-names>P. J.</given-names></name></person-group> (<year>2017</year>). <article-title>MicroRNAs regulate synaptic plasticity underlying drug addiction</article-title>. <source/>Genes, Brain, and Behavior,
<volume>17</volume>(<issue>3</issue>), <fpage>e12424</fpage>. doi:<pub-id pub-id-type="doi">10.1111/gbb.12424</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H. P.</given-names></name></person-group> (<year>2014</year>). <article-title>TARV: Tree-based analysis of rare variants identifying risk modifying variants in CTNNA2 and CNTNAP2 for alcohol addiction</article-title>. <source/>Genetic Epidemiology,
<volume>38</volume>(<issue>6</issue>), <fpage>552</fpage>–<lpage>559</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gepi.21843</pub-id><pub-id pub-id-type="pmid">25041903</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speed</surname><given-names>W. C.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Barta</surname><given-names>C.</given-names></name><name><surname>Pakstis</surname><given-names>A. J.</given-names></name><name><surname>State</surname><given-names>M. W.</given-names></name><name><surname>Kidd</surname><given-names>K. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Haplotype evolution of SLITRK1, a candidate gene for Gilles de la Tourette syndrome</article-title>. <source/>American Journal of Medical Genetics Part B-Neuropsychiatric Genetics,
<volume>147B</volume>(<issue>4</issue>), <fpage>463</fpage>–<lpage>466</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.b.30641</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolf</surname><given-names>A. R.</given-names></name><name><surname>Szobot</surname><given-names>C. M.</given-names></name><name><surname>Halpern</surname><given-names>R.</given-names></name><name><surname>Akutagava-Martins</surname><given-names>G. C.</given-names></name><name><surname>Muller</surname><given-names>D.</given-names></name><name><surname>Guimaraes</surname><given-names>L. S. P.</given-names></name><name><surname>Kessler</surname><given-names>F. H.</given-names></name><name><surname>Pechansky</surname><given-names>F.</given-names></name><name><surname>Roman</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Crack cocaine users show differences in genotype frequencies of the 3′ UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3)</article-title>. <source/>Neuropsychobiology,
<volume>70</volume>(<issue>1</issue>), <fpage>44</fpage>–<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000365992</pub-id><pub-id pub-id-type="pmid">25247548</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>K. A.</given-names></name><name><surname>Puffenberger</surname><given-names>E. G.</given-names></name><name><surname>Huentelman</surname><given-names>M. J.</given-names></name><name><surname>Gottlieb</surname><given-names>S.</given-names></name><name><surname>Dobrin</surname><given-names>S. E.</given-names></name><name><surname>Parod</surname><given-names>J. M.</given-names></name><name><surname>Stephan</surname><given-names>D. A.</given-names></name><name><surname>Morton</surname><given-names>D. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2</article-title>. <source/>The New England Journal of Medicine,
<volume>354</volume>(<issue>13</issue>), <fpage>1370</fpage>–<lpage>1377</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa052773</pub-id><pub-id pub-id-type="pmid">16571880</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdejo-Garcia</surname><given-names>A.</given-names></name><name><surname>Fagundo</surname><given-names>A. B.</given-names></name><name><surname>Cuenca</surname><given-names>A.</given-names></name><name><surname>Rodriguez</surname><given-names>J.</given-names></name><name><surname>Cuyas</surname><given-names>E.</given-names></name><name><surname>Langohr</surname><given-names>K.</given-names></name><name><surname>de Sola Llopis</surname><given-names>S.</given-names></name><name><surname>Civit</surname><given-names>E.</given-names></name><name><surname>Farré</surname><given-names>M.</given-names></name><name><surname>Peña-Casanova</surname><given-names>J.</given-names></name><name><surname>de la Torre</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in Cannabis users</article-title>. <source/>Neuropsychopharmacology,
<volume>38</volume>(<issue>8</issue>), <fpage>1598</fpage>–<lpage>1606</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2013.59</pub-id><pub-id pub-id-type="pmid">23449176</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A. J.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Joosse</surname><given-names>M.</given-names></name><name><surname>Eussen</surname><given-names>B. H.</given-names></name><name><surname>Heutink</surname><given-names>P.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name></person-group>, &amp; <collab>Tourette Syndrome Association International Consortium for Genetics</collab>. (<year>2003</year>). <article-title>CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder</article-title>. <source/>Genomics,
<volume>82</volume>(<issue>1</issue>), <fpage>1</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0888-7543(03)00097-1</pub-id><pub-id pub-id-type="pmid">12809671</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welte</surname><given-names>J. W.</given-names></name><name><surname>Barnes</surname><given-names>G. M.</given-names></name><name><surname>Tidwell</surname><given-names>M. C. O.</given-names></name><name><surname>Hoffman</surname><given-names>J. H.</given-names></name><name><surname>Wieczorek</surname><given-names>W. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Gambling and problem gambling in the United States: Changes between 1999 and 2013</article-title>. <source/>Journal of Gambling Studies,
<volume>31</volume>(<issue>3</issue>), <fpage>695</fpage>–<lpage>715</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10899-014-9471-4</pub-id><pub-id pub-id-type="pmid">24880744</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willour</surname><given-names>V. L.</given-names></name><name><surname>Seifuddin</surname><given-names>F.</given-names></name><name><surname>Mahon</surname><given-names>P. B.</given-names></name><name><surname>Jancic</surname><given-names>D.</given-names></name><name><surname>Pirooznia</surname><given-names>M.</given-names></name><name><surname>Steele</surname><given-names>J.</given-names></name><name><surname>Schweizer</surname><given-names>B.</given-names></name><name><surname>Goes</surname><given-names>F. S.</given-names></name><name><surname>Mondimore</surname><given-names>F. M.</given-names></name><name><surname>Mackinnon</surname><given-names>D. F.</given-names></name><collab>Bipolar Genome Study Consortium</collab><name><surname>Perlis</surname><given-names>R. H.</given-names></name><name><surname>Lee</surname><given-names>P. H.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Kelsoe</surname><given-names>J. R.</given-names></name><name><surname>Shilling</surname><given-names>P. D.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Nöthen</surname><given-names>M.</given-names></name><name><surname>Cichon</surname><given-names>S.</given-names></name><name><surname>Gurling</surname><given-names>H.</given-names></name><name><surname>Purcell</surname><given-names>S.</given-names></name><name><surname>Smoller</surname><given-names>J. W.</given-names></name><name><surname>Craddock</surname><given-names>N.</given-names></name><name><surname>DePaulo</surname><given-names>J. R.</given-names><suffix>Jr.</suffix></name><name><surname>Schulze</surname><given-names>T. G.</given-names></name><name><surname>McMahon</surname><given-names>F. J.</given-names></name><name><surname>Zandi</surname><given-names>P. P.</given-names></name><name><surname>Potash</surname><given-names>J. B.</given-names></name></person-group> (<year>2012</year>). <article-title>A genome-wide association study of attempted suicide</article-title>. <source/>Molecular Psychiatry,
<volume>17</volume>(<issue>4</issue>), <fpage>433</fpage>–<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2011.4</pub-id><pub-id pub-id-type="pmid">21423239</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>R. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Dopamine, learning and motivation</article-title>. <source/>Nature Reviews Neuroscience,
<volume>5</volume>(<issue>6</issue>), <fpage>483</fpage>–<lpage>494</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn1406</pub-id><pub-id pub-id-type="pmid">15152198</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xuan</surname><given-names>Y. H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Tao</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>L. L.</given-names></name><name><surname>Wang</surname><given-names>X. T.</given-names></name><name><surname>Zheng</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic and environmental influences on gambling: A meta-analysis of twin studies</article-title>. <source/>Frontiers in Psychology,
<volume>8,</volume>
<fpage>2121</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2017.02121</pub-id><pub-id pub-id-type="pmid">29259572</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>T.</given-names></name><name><surname>Usui</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Yoshimi</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Aleksic</surname><given-names>B.</given-names></name><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Inada</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Uchimura</surname><given-names>N.</given-names></name><name><surname>Iwata</surname><given-names>N.</given-names></name><name><surname>Sora</surname><given-names>I.</given-names></name><name><surname>Iyo</surname><given-names>M.</given-names></name><name><surname>Ozaki</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population</article-title>. <source/>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry,
<volume>35</volume>(<issue>5</issue>), <fpage>1268</fpage>–<lpage>1272</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pnpbp.2011.04.003</pub-id><pub-id pub-id-type="pmid">21514351</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>